Skip to main content

Status™ COVID-19/Flu A&B

Covid-19 Flu A&B

Available Now!


A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen 


  • Sensitivity and Specificity
       − COVID-19 - Sensitivity 93.9%, Specificity 100%
       − Flu A - Sensitivity 91.4%, Specificity 95.7%
       − Flu B - Sensitivity 87.6%, Specificity 95.9%
  • FDA Emergency Use Authorization (EUA)
  • Visually read in 15 minutes
  • Flocked nasopharyngeal swab for superior specimen collection and patient comfort


CPT COVID-19: 87811QW
FLU A: 87804QW
FLU B: 87804QW-59